Skip to main content

Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

allogeneic virus-specific T lymphocytes

A preparation of allogeneic donor-derived T lymphocytes that are specifically reactive to adenovirus (AdV), cytomegalovirus (CMV), Epstein-Barr virus (EBV) and human polyomavirus type I (BKV), with potential antiviral activity. Upon administration, allogeneic VSTs may kill AdV, CMV, EBV and/or BKV-infected cells, thereby preventing or reducing the severity of viral infections by these pathogens.

Check for active clinical trials using this agent View this agent in the NCI Thesaurus

Synonym:	allogeneic viral-specific T cells allogeneic VSTs

allogeneic virus-specific T lymphocytes

Search NCI's Drug Dictionary